Kaitai Capital

Kaitai Capital

Hangzhou based venture capital management company investing in innovative technology companies in multiple industries

Kaitai Capital is a Hangzhou based venture capital management company investing in innovative technology companies in multiple industries world wide. Kaitai focuses its investments on biotechnology, medicine, healthcare services, agriculture tech, consumer business, outdoor sports, financial services, artificial intelligence, and digital technology. Founded in 2009, it has physical presence in San Jose, United States, and Hangzhou and Beijing in China. As of 2019, the company has invested in 28 companies with two successful exits.

Timeline

Funded Companies

Company
Description
Industry
Website
Location
OncoImmune

A clinical-stage biopharmaceutical company engaging in drug discovery and drug development for treating autoimmune disease and cancer.

Totient is a San Francisco-based company founded by Kevin Britz.

Totient is a Cambridge, Massachusetts-based company.

Amphivena Therapeutics is a San Francisco-based company.

4 Results
Results per page:
Page 1 of 1

People

Name
Role
LinkedIn

Chuangen zhou

Partner

Datao cheng

Partner

Fangcai xu

Partner

Hao xu

Partner

Huadi dong

Brand manager

Huan liu

Associate

Lei chen

Partner

Lei liu

Vice president

Liangchang Fang

Partner

Linfu WANG

Partner

Xiaotong qin

Associate

Xiaying huang

Associate

Yin chen

Vice president

Yonghong XU

Founding partner

Yuanbo li

Vice president

Zhongbao li

Associate

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services
Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.